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Abstract
Background: The mechanism explaining the increased disease susceptibility in aging is not well
understood. CD8+ T cells are crucial in anti-viral and anti-tumor responses. Although the
chemokine system plays a critical role in CD8+ T cell function, very little is known about the
relationship between aging and the T cell chemokine system.
Results: In this study we have examined the effect of aging on murine CD8+ T cell chemokine
receptor gene expression. Freshly isolated splenic CD8+ T cells from old C57BL/6 mice were
found to have higher CCR1, CCR2, CCR4, CCR5 and CXCR5, and lower CCR7 gene expression
compared to their younger cohort. Anti-CD3/anti-CD28 stimulation elicited a similar robust
chemokine receptor response from young and old CD8+ T cells. Western blot analyses confirmed
elevated protein level of CCR4 and CCR5 in aged CD8+ T cells. Increases in T cell CCR1 and
CCR5 expression also correlate to increased in vitro chemotaxis response to macrophage-
inflammatory protein-1 α(MIP-1α). Finally, caloric restriction selectively prevents the loss of CD8+
T cell CCR7 gene expression in aging to the level that is seen in young CD8+ T cells.
Conclusion: These findings are consistent with the notion that aging exists in a state of low grade
pro-inflammatory environment. In addition, our results provide a potential mechanism for the
reported aging-associated impaired T cell lymphoid homing and allograft response, and reduced
survival in sepsis.
Background
The aging-associated susceptibility to infection and cancer
is often attributed to the decline in immune response in
the elderly [1]. Impaired T cell proliferation, receptor sig-
naling, interleukin-2 response, and the expansion of
memory T cells have been documented in both human
and murine aging. However, a direct relationship between
the observed T cell hyporeactivity and clinical disease has
not been established. Paradoxically, exaggerated inflam-
matory response has been linked to increased mortality
from overwhelming sepsis [2,3], cardiovascular disease,
and geriatric syndromes such as sarcopenia [4,5], frailty
[6,7], as well as to all cause mortality [6]. There is a grow-
ing recognition that while inflammatory responses confer
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short term benefits, chronic low grade inflammation may
actually contribute to the susceptibility and clinical man-
ifestation of diseases in aging. However, the pathogenic
basis behind these observations remains poorly under-
stood. Furthermore, the source of the inflammatory medi-
ators in aging is uncertain. Lastly, it is unclear if the
inflammatory response observed in aging is secondary to
disease or to the aging process.
Chemokines, or chemotactic cytokines, are a superfamily
of at least forty small (8–10 kDa) proteins [8,9]. They are
grouped together based on sequence homology and are
classified according to the amino terminal cysteine motif
into C, CC, CXC, and CX3C chemokines. At least 20
chemokine receptors have been cloned. Chemokines and
their receptors are Janus molecules that participate in
physiological responses and at the same time play a criti-
cal role in the pathogenesis of diverse diseases that are
important in the elderly population, including sepsis [10],
atherosclerosis [11,12], tumor rejection [11], diabetes
[13,14] and rheumatoid arthritis [15]. Age-associated
change in chemokine function may therefore have signif-
icant impact on both the normal and pathological inflam-
matory responses in the elderly. Importantly, the
overlapping ligand-receptor specificity this system exhib-
its suggests a degree of redundancy. It is the coordinated
interaction among chemokines and their receptors that
define the in vivo multicomponent physiological and
pathological responses [11]. Surprisingly, little is known
about the effect of aging on the chemokine system.
CD8+ T cells, or cytotoxic T lymphocytes, are essential
members of the immune system involved in tumor sur-
veillance and in combating viral infections. A number of
changes occur in CD8+ T cells in aging, including elevated
percentage and number of memory CD8+ T cells, the
accumulation of CD28-CD8+ T cells [16], and lost of Fas
expression [17]. The coordinated migration of CD8+ T
cells to peripheral tissues where they perform their effec-
tor function is a chemokine/chemokine receptor-depend-
ent process. Thus, the absence of CCR7 impairs the
magnitude of CD8+ T cell anti-viral response, with
reduced number of virus-specific CD8+ cells in both lym-
phoid and nonlymphoid organs [18]. Similarly, low
CCR4 and CXCR3 expression on CD8+ T cells has been
linked to dampened anti-tumor response and poor sur-
vival in metastatic melanoma patients [19]. Paradoxically,
CD8+ T cells are also involved in the pathogenesis of
selected diseases prevalent in the elderly. For example,
accumulation of CD8+ T cells in atherosclerotic plaques
has been proposed as a mechanism contributing to the
widespread apoptosis found within these lesions [20].
Aging associated changes in chemokine receptor expres-
sion may therefore alter important migratory and effector
functions of CD8+ T cells. In this report, we investigated
the role of aging in determining murine CD8+ T cell CC
and CXC chemokine receptor gene expression.
Results
Aging and CD8+ T cell chemokine receptor gene 
expression
We compared the CC and CXC chemokine receptor gene
expression of CD8+ T cells from young and old C57BL/6
mice using RPA probe sets that included CCR1–5, and
CXCR2, 4 and 5 as before [21]. The results (Figure 1) indi-
cated that freshly isolated old CD8+ T cells have signifi-
cantly higher level of CCR1, CCR2, CCR4, CCR5 and
CXCR5 gene expression than those from young CD8+ T
cells. Smaller changes in CCR3, CXCR2 and CXCR4 gene
expression were seen, but the results did not reach statisti-
cal significance.
T cell receptor stimulation and T cell chemokine receptor 
expression
Chemokine receptor expression profile is altered follow-
ing the engagement of the TCR to the major histocompat-
ibility complex (MHC) on antigen presenting cells. For
example, receptors for constitutively expressed chemok-
ines such as CXCR4 and CCR7 are down-regulated as
naïve T cells are activated and differentiated into effector
cells [22]. This in turn allows the CD8+ T cells to migrate
to peripheral tissues to perform their effector function.
Others have reported that specific T cell dysfunctions in
aging can also be rescued by co-activating the TCR and T
cell co-stimulation pathways [23-25]. We therefore deter-
mined the combined effect of T cell receptor (CD3)/cos-
timulatory molecule (CD28) stimulation on young and
old CD8+ T cell chemokine receptor expression profile
(Figure 2). The results show that the CD8+ T cells CCR1,
2, 3, 5 and CXCR2, 4, 5 gene expression decreases after the
CD3/CD28 activation. CCR4 is the only chemokine
receptor that showed increased expression following anti-
CD3/anti-CD28 mAb treatments, similar to what has
been seen in CD4+ T cells [21]. Despite the age difference
in basal chemokine receptor gene expression level, old
CD8+ T cells exhibit similar robust CC and CXC chemok-
ine receptor response to TCR/co-stimulatory activation as
young CD8+ T cells.
Caloric restriction and CD8+ T cell chemokine receptor 
expression
Caloric restriction has been shown to prolong life in mice
and to restore many of the aging-associated defects in T
cell immune functions [26]. In addition, caloric restric-
tion may affect CD4+ T cell chemokine receptor gene
expression in aging [21]. In the current study we did not
see any significant effect of caloric restriction on CD8+ T
cell chemokine receptor expression compared to ad lib fed
mice (Figure 3A). Although the CD8+ T cell CCR1, CCR3
and CXCR4 expression in caloric restricted mice approxi-Immunity & Ageing 2007, 4:8 http://www.immunityageing.com/content/4/1/8
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Murine CD8+ T cell chemokine receptor gene expression Figure 1
Murine CD8+ T cell chemokine receptor gene expression. Autoradiographs of representative ribonuclease protection assay 
(RPA) comparing young (Y) (3–4 months old) and old (O) (18–20 months old) C57BL/6 CD8 T cell CCR1–5 (A) and CXCR2, 
4 and 5 (B) gene expression. Composite histogram (C) of 5 RPAs using pooled RNA from a total of 25 mice in each age group 
is shown. The quantitation was done by measuring the P32-radiation from identical size band areas on the RPA gel using a Phos-
phoimager. The results represent the mean ± SEM of the chemokine receptor gene expression level of old CD8+ T cells rela-
tive to young CD8+ T cells (arbitrarily defined as equal to 1). Gel loading is corrected with L32 expression. P value of ≤ 0.05 is 
considered statistically significant. * P ≤ 0.05, ** P ≤ 0.005, *** P ≤ 0.001, NS = not significant.
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Murine CD8+ T cell chemokine receptor gene expression following T cell receptor/CD28 stimulation Figure 2
Murine CD8+ T cell chemokine receptor gene expression following T cell receptor/CD28 stimulation. Autoradiographs of 
representative ribonuclease protection assay (RPA) showing the effect of aging and anti-CD3/anti-CD28 monoclonal antibody 
(mAb) stimulation on murine CD8+ T cell CCR1–5 (A) and CXCR2, 4 and 5 (B) gene expression. Lane 1 in Figure 2A and Lane 
2 in Figure 2B = Young (3–4 months) unstimulated cells; Lane 2 in Figure 2A and Lane 3 in Figure 2B = Old (18–20 months) 
unstimulated cells; Lane 3 in Figure 2A and Lane 4 in Figure 2B = Young cells after 72 hours of anti-CD3/anti-CD28 mAb stim-
ulation; Lane 4 in Figure 2A and Lane 5 in Figure 2B = Old cells after 72 hours of anti-CD3/anti-CD28 mAb stimulation; Lane 5 
in Figure 2A and Lane 1 in Figure 2B = unprotected probe set. Composite histogram (C) of 3 RPAs using pooled RNA from a 
total of 15 animals in each age group is shown. Gel loading is corrected with L32 expression.
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mates that seen in the young mice, the results did not
reach statistical significance. We also examined the effect
of caloric restriction on CCR7 expression using a custom
RPA probe set as before [21]. The results show reduced
CCR7 expression in old CD8+ T cells, similar to that
reported in CD4+ T cells in aging [21,27]. Interestingly,
caloric restriction selectively prevents the loss of CCR7
expression in CD8+ T cells (Figure 3B).
Chemokine receptor protein levels in CD8+ T cells in aging
Since most chemokine receptors remain in the intracellu-
lar compartment and cell surface chemokine receptors
constantly go through clathrin-mediated internalization
and recycling, flow cytometric analysis of chemokine
receptor cell surface expression may not correlate with
changes in chemokine receptor gene expression. We there-
fore determined the chemokine receptor protein level by
Western blot analysis using total cell lysate. Western blot
analyses were done using anti-CCR4 and anti-CCR5 anti-
bodies as before [21]. The results showed that the detected
increase CCR4 and CCR5 gene expression in CD8+ T cells
in aging correlates with increase CCR4 and CCR5 protein
levels in aging (Figure 4).
CD8+ T cell MIP-1α chemotaxis response in aging
To determine if increased chemokine receptor gene
expression correlates to increase CD8+ T cell chemotaxis
function, we compared the in vitro migration response of
young and old CD8+ T cells to MIP-1α (Figure 5), a ligand
for CCR1 and CCR5. The results showed increased migra-
tion of old CD8+ T cells to the chemokine, confirming
functional significance of the increased CCR1 and 5
expressions in old CD8+ T cells.
Conclusion
Aging is associated with a myriad of changes in immune
functions. Despite the widely held notion that aging
causes impaired immune and inflammatory responses,
there is now considerable evidence that not all aspects of
immune functions are adversely affected in the elderly.
Little is known about the effect of aging on T cell chemok-
ine response. We have previously shown that murine
CD4+ T cells expressed a higher level of CCR1, 2, 4, 5, 6
and 8 and CXCR2–5, and lower level of CCR7 and 9 [21].
To the best of our knowledge, the current study is the first
systematic report of the effect of aging on CD8+ T cell
chemokine receptor gene expression. Our results demon-
strated age-related increase in CD8+ T cell CCR 1, 2, 4, 5
and CXCR5, and reduced CCR7 gene expression. These
results are similar to that we reported in CD4+ T cells, sug-
gesting that similar mechanisms are responsible for the
observed aging-dependent differences in both cell types.
We further showed that increase CCR4 and CCR5 gene
expression in aging correlates to increase CCR4 and CCR5
protein levels.
The downregulation of selected chemokine receptor fol-
lowing TCR activation is consistent with what has been
reported in the literature [21,27-31]. One group of inves-
tigators showed that memory/effector T cells undergo a
further but transient switch in chemokine receptor expres-
sion following TCR stimulation, including down regula-
tion of CCR1, 2, 3, 5, 6 and CXCR3, and upregulation of
CCR4 [22]. In the current study, we also found that CCR4
expression increases following anti-CD3/CD28 stimula-
tion. Despite the elevated basal level of chemokine recep-
tor genes, old CD8+ T cells showed a robust response to T
cell receptor/co-stimulatory activation to a similar degree
seen in their younger cohort.
Memory and naïve T cells tend to express a different com-
bination of chemokine receptors. Aging is also known to
be associated with reduced CD8 T cell clonal (antigen
receptor) diversity. The reason for the observed chemok-
ine receptor gene expression changes may therefore be in
part explained by the bias toward memory T cells in aging.
However, although we did not specifically investigate the
naïve and memory CD8+ T cell subsets, this seems
unlikely to be the sole explanation as we have previously
shown that aging has similar effect on naïve and memory
CD4+ T cells chemokine receptor gene expression [32].
Furthermore, although old caloric restricted mice have
fewer memory T cells [26], our results showed that they
have similar T cell chemokine receptor expression profile
as old mice receiving ad lib feeding (except CCR7).
Finally, our data showed that although the memory T cell-
associated chemokine receptors (e.g. CCR4 and CCR5)
are upregulated in aging, we also detected a small increase
in naïve T cell associated chemokine receptor CXCR4 that
can not be due to the reduced naïve T cell population in
aging.
Restricting caloric intake has been shown to extend life
span in invertebrates (e.g. C. elegans, Drosophilla), short-
lived vertebrates (e.g zebra fish) and rodents [reviewed in
[33]]. In addition, caloric restriction is a key environmen-
tal manipulation that has been shown to modulate T cell
function in aging, including maintaining naïve T cell pop-
ulation, T cell proliferation capacity and death responses.
Surprisingly, our results showed that caloric restriction
has relatively little effect on CD8+ T cell chemokine recep-
tor gene expression, suggesting a different mechanism of
control. As stated above, the only exception is CD8+ T cell
CCR7 expression. Similar to what we and others have
reported in CD4+ T cells [21,27], we found that CCR7
expression on freshly isolated CD8+ T cells decreases with
aging in ad lib fed mice. This is also consistent with a
recent report showing decreased CCR7 expression in the
respiratory syncytial virus-specific CD8+ memory T cell
responses in elderly persons [33]. However, our results do
not exclude the obvious possibility that increased inImmunity & Ageing 2007, 4:8 http://www.immunityageing.com/content/4/1/8
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The effect of caloric restriction on CD8+ T cell chemokine receptor expression in aging Figure 3
The effect of caloric restriction on CD8+ T cell chemokine receptor expression in aging. Ribonuclease protection assays 
(RPAs) were done using RNA from freshly isolated splenic CD8+ T cells from young (3–4 months), old (18–20 months), and 
caloric restricted old (18–20 months) mice in groups of 5 animals. Density of the bands was quantified using a phosphoimager. 
(A) Histogram showing the composite data of 4 experiments (total 20 animals in each condition). The results represent the 
mean ± SEM of the relative CD8+ T cell chemokine receptor gene expression level of old and old caloric restricted mice com-
pared to those from the young cohort (arbitrarily defined as equal to 1). (B) CCR7 expression was also determined using a 
custom CCR7 RPA probe. The left panel is a representative autoradiograph (lane 1 = young CD8+ T cells; lane 2 = old CD8+ 
T cells; lane 3 = caloric restricted old CD8+ T cells). The right panel represents the composite data of 3 RPAs with a total of 
15 animals in each group. Results are presented as mean ± SEM. CR = caloric restricted. Gel loading is corrected with L32 
expression.
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memory T cells in aging may be responsible for the
observed CCR7 results. Interestingly, CCR7 expression in
caloric restricted mice is similar to the level seen in young
CD8+ T cells. The reason for the selected CCR7 response
to caloric restriction is unknown. Recent works suggest
that CCR7 may be under the control of epigenetic factors
[34], and we are currently exploring this as a potential
mechanism controlling chemokine receptor expression in
aging. Of interest, CCR7 has been reported to play an
important role in protecting CD8+ T cells from apoptosis
[35]. It is therefore tempting to postulate that the low
CCR7 expression in aging CD8+ T cells may contribute to
their resistant to undergo apoptosis that some investiga-
tors have reported [36,37]. A role of CCR7 in CD8+ T cell
in lymphoid migration has also been firmly established
[38]. The observed age-associated reduction in CCR7
expression may therefore help explain the observed
impaired lymphocyte lymphoid homing in aging [39-42].
Lastly, recent investigation showed that CCR7-/- mice
have prolonged allograft survival accompanied by a delay
in the cellular infiltration of the allograft [43]. Reduced T
cell CCR7 expression in aging provides a potential novel
mechanism contributing to the observed reduced allograft
rejection and improved organ transplantation in the eld-
erly [44,45].
The observed aging changes in CD8+ T cell chemokine
receptor gene expression may also have an impact on
other aging related conditions. For example, CCR1-/- mice
have improved survival in experimental sepsis [10] and
Western blot analyses of CCR4 and CCR5 protein level in aged CD8+ T cells Figure 4
Western blot analyses of CCR4 and CCR5 protein level in aged CD8+ T cells. Intracellular proteins were isolated from groups 
of 4–6 young and old C57Bl/6 mice. (A) Western blot analysis of CCR4 using proteins from 4 groups of young (Y1–Y4) and old 
(O1–O4) CD8+ T cells (total 20 young and 20 old mice). (B) Western blot analysis of CCR5 on CR8+ T cells isolated from 5 
groups of young (Y1–Y5) and Old (O1–O5) mice (total 25 young and 25 old mice). (C) Histogram showing the composite 
results of the relative CCR4 and CCR5 protein level of old CD8+ T cells compared to young CD8+ T cells. Pairwise compar-
ison was done for each individual sample preparation (Y1 versus O1, Y2 versus O2 etc., with the young group arbitrarily 
assigned the value of 1). The results are corrected for gel loading using β-actin as controls. The results are presented as mean 
± SD.
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the age-related increase in T cell CCR1 may contribute to
the observed increased mortality in septicemia in aging
[46,47]. Mice lacking CCR5 unexpectedly were found to
have enhanced delayed-type hypersensitivity and
increased humoral response to T cell-dependent antigenic
challenge [48]. The immunosuppressive effect of CCR5 is
also seen in a recent report showing that CCR5 plays a role
in downregulating donor alloreactive CD8+ T-cell expan-
sion in allogeneic bone marrow transplants [49]. Thus,
the increased CCR5 expression on aged T cells may also
contribute to the observed reduced allograft rejection and
increased susceptibility to infection in aging.
Aging can be defined as a process where an individual
organism progressively becomes increasingly susceptible
to disease (e.g. infections and cancer) and mortality. The
mechanisms for aging are not well defined, with genetic,
epigenetic and environmental factors implicated in its
pathogenesis. Our study provides the first systematic anal-
ysis of murine CD8+ T cell chemokine receptor gene
expression in aging. The observed selected CD8+ T cell CC
and CXC chemokine receptor overexpression in aging
may predispose the elderly to chemokine-dependent dis-
eases such as sepsis and cardiovascular disease. Con-
versely, impaired CCR7 expression may provide a
mechanism for impaired T cell lymphoid homing anti-
viral responses, and improved allograft survival in the eld-
erly population.
Methods
Mice
Young (3–4 months), old (18–20 months) and old
caloric-restricted (18–20 months) C57BL/6 mice were
obtained from the National Institute on Aging (NIA) Aged
Rodent Colonies through Harlan Sprague Dawley (Indi-
anapolis, IN). The caloric restriction protocol is published
in the NIA website. Briefly, caloric restriction is initiated at
14 weeks of age at 10% restriction, then 25% and 40%
restriction at 15 and 16 weeks respectively [21]. All mice
were maintained in a pathogen-free environment pro-
vided by the Unit for Laboratory Animal Medicine at the
University of Michigan (Ann Arbor, MI) until they were
used. Careful inspection of the animal was done at the
time of sacrifice to exclude aged animals with cancer or
lymphoma. All the experimental research in the current
study have been approved by the University of Michigan
University Committee on Use and Care of Animals
(UCUCA).
CD8+ T cell isolation
Splenic CD8+ T cells were negatively selected using a com-
bination of CD4 (L3T4), CD45R (B220), CD49b (DX5),
CD11b (Mac-1) and Ter-119 microbeads (Miltenyi Bio-
tec, Auburn, CA) as before [21,50]. Alternately, in some
experiments the cells were isolated by positive selection
using the CD8a (Ly-2) microbeads. Purity of the cells iso-
lated using either method was confirmed by flow cyto-
metric analyses, and was consistently >96%.
T cell culture and T cell receptor (TCR) stimulation
All the monoclonal antibodies (mAbs) were obtained
from BD PharMingen (San Diego, CA) unless otherwise
stated. Combined anti-CD3 and anti-CD28 mAbs were
used to provide maximum TCR/co-stimulation to the
CD8+ T cells [21]. Briefly, anti-CD3e (2.5 μg/ml final con-
centration) was diluted in PBS and immobilized to the
individual wells of 6-well flat bottom tissue culture plates
(Corning Glass Works, Corning, NY) in a final volume of
6 ml for overnight. The plates were then washed with PBS
twice. 1 × 106 purified CD8+ T cells were then cultured in
6 ml media containing RPMI 1640 medium supple-
mented with 10% FBS, 2-ME and anti-CD28 (2.25 μg/ml
final concentration) in a humidified atmosphere at 5%
CO2 at 37°C for 72 hours. RNAs from unstimulated and
anti-CD3/anti-CD28 stimulated cells were isolated by
TRIzol®LS reagent (Life Technologies, Grand Island, NY),
and a second cleanup step performed using the Qiagen
RNeasy Total RNA isolation kit (Qiagen, Valencia, CA).
Effect of aging on murine CD8+ T cell chemotaxis response  to MIP-1α Figure 5
Effect of aging on murine CD8+ T cell chemotaxis response 
to MIP-1α. The indicated concentrations of the chemokine 
were placed in the lower chamber of a Costar Transwell sys-
tem. Equal number of freshly isolated young (3–4 months) or 
old (18–20 months) CD8+ T cells was then placed in the 
upper chamber of the insert, and the number of cells in the 
upper and lower chambers counted 5 hours later using a 
Coulter counter. The results are expressed as percent trans-
migration and represent the mean ± SD of triplicate determi-
nations. P ≤ 0.05 is considered significant. The results are 
representative of 3 independent experiments.
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Intracellular proteins were isolated from the phenol-etha-
nol supernate with isopropyl alcohol after precipitation
with ethanol, as per standard protocol.
RNase protection assays (RPAs)
Chemokine receptor gene expression was quantified by
RPAs as before [21,50]. Briefly, pooled RNAs from equal
number of purified CD8+ T cells from young and old mice
in groups of 4–6 animals were used for each experiment
to minimize individual variability. The probes were syn-
thesized by modification of the manufacturer's protocol.
Briefly, GACU nucleotide pool and [α-32P]UTP, RNasin,
T7 RNA polymerase were added to the multi-probe tem-
plate set mCR-5 (CCR1–5), mCR-6 (CXCR2, 4, and 5) or
a custom probe set containing CCR7 [21] (all from BD
PharMingen, San Diego, CA) and placed on heat block at
37° for 1 hour. The reaction was terminated by adding
DNase and incubated at 37°C on a heat block for 30 min-
utes. Appropriate volumes of EDTA, Tris-saturated phe-
nol, chloroform:isoamyl alcohol (CIAA, 50:1) and yeast
tRNA were then added to the mixture, as suggested by the
manufacturer. The aqueous layer was extracted by CIAA,
then pelleted by adding a 1:5, 4 M ammonium acetate and
ice-cold 100% ethanol mixture. 5 μg of total RNA from
each T cell sample was used for hybridization. The pro-
tected probes were then fractionated by electrophoresis
through a 5% acrylamide gel, exposed to a phosphor
screen and quantified by a Phosphorimager using Image
Quant software (Molecular Dynamics). The signals quan-
tified were in the linear range.
In vitro chemotaxis assays
Dual chamber chemotaxis assays were performed to com-
pare the MIP-1α (CCL3; ligand for CCR1 and 5) (Pepro-
Tech, Rocky Hill, NJ) response of CD8+ T cells from
young and old animals. Briefly, freshly isolated 4 × 105 T
cells in 100 μl RPMI 1640 medium supplemented with
0.5% BSA were placed in Transwell Clear culture inserts
with 5 μm pores (Corning-Costar, Cambridge, MA). The
inserts were then placed in 24-well tissue culture plate
(Corning-Costar) containing 600 μl of the indicated con-
centrations of murine MIP-1α in RPMI 1640 medium
supplemented with 0.5% BSA for 5 hours in a humidified
incubator at 37°C. Cells from the top and bottom cham-
bers were then harvested and counted with a Beckman
Coulter counter.
Western blots
Proteins from young and old CD8+ T cells were resolved
on 10% SDS-polyacrylamide gels and transferred to Nitro-
cellulose-1 membrane (Life Technologies, Inc., Gaithers-
burg, MD). The membrane was blocked in PBS containing
5% nonfat dry milk, and 0.05% Tween 20 and subse-
quently incubated with anti-mouse CCR4 or CCR5 anti-
bodies (BD PharMingen) followed by HRP-conjugated
anti-rabbit and anti-rat IgG F(ab')2 (Amersham Life Sci-
ence). Detection was performed using the ECL system
(Amersham). The membranes were then stripped and re-
probed with anti-mouse-β-actin antibodies (Sigma, MO)
to confirm equal protein loading.
Statistical analyses
Data were analyzed using analysis of variance (ANOVA)
or Student's t-test, with Bonferroni corrections for multi-
ple comparisons where appropriate. Statistical signifi-
cance was set at P < 0.05.
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